Data as of Oct 30
| +0.28 / +0.23%|
The 19 analysts offering 12-month price forecasts for Edwards Lifesciences Corp have a median target of 120.00, with a high estimate of 135.00 and a low estimate of 92.00. The median estimate represents a -0.23% decrease from the last price of 120.28.
The current consensus among 23 polled investment analysts is to Buy stock in Edwards Lifesciences Corp. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.